Find My Journal

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

Matti Lehtinen, Jorma Paavonen, Cosette M. Wheeler, Unnop Jaisamrarn, Suzanne M. Garland, Xavier Castellsagué, S. Rachel Skinner, Dan Apter, Paulo Naud, Jorge Salmerón, Song-Nan Chow, Henry C Kitchener, Júlio César Teixeira, James Hedrick, Genara Limson, Anne Szarewski, Barbara Romanowski, Fred Y. Aoki, Tino F. Schwarz, Willy Poppe, Newton Sérgio de Carvalho, Maria Julieta V. Germar, Klaus Peters, Adrian Mindel, P. De Sutter, F. Xavier Bosch, Marie-Pierre David, Dominique Descamps, Frank Struyf, Gary Dubin

The Lancet Oncology, 2011

Tampere University, Tampere University, University of Helsinki, University of New Mexico, Centro de Investigación Biomédica en Red, Institut Català d'Oncologia, Institut d'Investigació Biomédica de Bellvitge, The University of Sydney, The Kids Research Institute Australia, Sexual Health Clinic, Väestöliitto, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Mexican Social Security Institute, National Taiwan University Hospital, St Mary's Hospital, Manchester Academic Health Science Centre, Universidade Estadual de Campinas (UNICAMP), Ohio Pediatric Research Association, Philippine General Hospital, Makati Medical Center, Queen Mary University of London, University of Alberta, University of Manitoba, Stiftung Juliusspital, KU Leuven, Klinik für Frauenheilkunde, Westmead Hospital, GlaxoSmithKline (Belgium), GlaxoSmithKline (United States)

Publisher Website

Abstract

An abstract is not available for this record. Please visit the publisher website for more details.

699

Citations

View on Google Scholar